https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-11-07 / World Neurosurg 2012 May-Jun;77(5-6):736-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-11-07 / World Neurosurg 2012 May-Jun;77(5-6):736-442011-11-07 00:00:002019-02-15 08:46:33Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-08-31 / Rev. Neurol. (Paris) 2011 Oct;167(10):668-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-08-31 / Rev. Neurol. (Paris) 2011 Oct;167(10):668-722011-08-31 00:00:002019-02-15 08:46:37Immunotherapy in human glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-07-22 / Neuro-oncology 2011 Oct;13(10):1049-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-07-22 / Neuro-oncology 2011 Oct;13(10):1049-582011-07-22 00:00:002019-02-15 08:46:38Treatment of high-grade glioma in children and adolescents
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-28 / J Clin Neurosci 2011 Aug;18(8):1048-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-28 / J Clin Neurosci 2011 Aug;18(8):1048-542011-06-28 00:00:002019-02-15 08:46:40A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-06 / J Clin Oncol 29: 2011 (suppl; abstr 2508)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-06 / J Clin Oncol 29: 2011 (suppl; abstr 2508)2011-06-06 11:53:442019-07-17 11:54:11Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-06-01 / Clin. Cancer Res. 2011 Jul;17(14):4705-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-06-01 / Clin. Cancer Res. 2011 Jul;17(14):4705-182011-06-01 00:00:002019-02-15 08:46:41Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-05-01 / J. Immunother. 2011 May;34(4):382-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-05-01 / J. Immunother. 2011 May;34(4):382-92011-05-01 00:00:002019-02-15 08:46:42Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-02-19 / J. Neurooncol. 2011 Sep;104(3):659-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-02-19 / J. Neurooncol. 2011 Sep;104(3):659-672011-02-19 00:00:002019-02-15 08:46:14Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Curr. Pharm. Des. 2011;17(23):2439-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Curr. Pharm. Des. 2011;17(23):2439-672011-01-01 00:00:002019-02-15 08:46:39New perspectives in glioma immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-13 / J. Clin. Oncol. 2011 Jan;29(3):330-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-13 / J. Clin. Oncol. 2011 Jan;29(3):330-62010-12-13 00:00:002019-02-15 08:46:44Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
